Astec Lifesciences drops after weak Q4 outcome

Astec Lifesciences lost 3.23% to Rs 627 at 09:21 IST on BSE after consolidated net profit dropped 38.21% to Rs 3.46 crore on 8.28% rise in total income to Rs 90.50 crore in Q4 March 2017 over Q4 March 2016.

The result was announced after market hours yesterday, 4 May 2017.

Meanwhile, the S&P BSE Sensex was down 118.69 points or 0.39% at 30,007.52. The S&P BSE Small-Cap index was down 11.20 points or 0.07% at 15,474.55.

On the BSE, 10,000 shares were traded on the counter so far as against the average daily volumes of 18,437 shares in the past one quarter. The stock had hit a high of Rs 640 and a low of Rs 624 so far during the day. The stock had hit a record high of Rs 694.80 on 20 December 2016 and a 52-week low of Rs 206 on 5 May 2016.

 

The small-cap company has equity capital of Rs 19.51 crore. Face value per share is Rs 10.

Astec Lifesciences is a producer of agrochemicals and pharmaceutical intermediates.

Powered by Capital Market - Live News